InsiderClue
Stocks · Health care · Pharmaceutical Preparations

LIGAND PHARMACEUTICALS INC

LGND Clue Score50
United States Fiscal year ends December CIK 0000886163 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

93
Insider
Date
Role
Action
Shares
Price
Amount
Andrew Reardon
2 Nov 2026
CLO & Secretary
Sold after exercise
120
$323.14
$38.78K
Andrew Reardon
2 Nov 2026
CLO & Secretary
Sold after exercise
200
$321.44
$64.29K
Andrew Reardon
2 Nov 2026
CLO & Secretary
Sold after exercise
320
$319.97
$102.39K
Andrew Reardon
2 Nov 2026
CLO & Secretary
Sold after exercise
440
$318.73
$140.24K
Andrew Reardon
2 Nov 2026
CLO & Secretary
Sold after exercise
280
$317.91
$89.01K
Andrew Reardon
2 Nov 2026
CLO & Secretary
Sold after exercise
80
$314.58
$25.17K
Andrew Reardon
2 Nov 2026
CLO & Secretary
Sold after exercise
403
$313.75
$126.44K
Andrew Reardon
2 Nov 2026
CLO & Secretary
Sold after exercise
634
$312.85
$198.35K
Andrew Reardon
2 Nov 2026
CLO & Secretary
Sold after exercise
520
$311.72
$162.09K
Andrew Reardon
2 Nov 2026
CLO & Secretary
Sold after exercise
490
$310.61
$152.20K
Andrew Reardon
2 Nov 2026
CLO & Secretary
Sold after exercise
522
$309.91
$161.77K
Andrew Reardon
2 Nov 2026
CLO & Secretary
Sold after exercise
708
$308.43
$218.37K
Andrew Reardon
2 Nov 2026
CLO & Secretary
Sold after exercise
283
$307.39
$86.99K
Andrew Reardon
2 Oct 2026
CLO & Secretary
Sold after exercise
17
$307.74
$5.23K
Andrew Reardon
2 Oct 2026
CLO & Secretary
Sold after exercise
235
$307.19
$72.19K
Andrew Reardon
2 Oct 2026
CLO & Secretary
Sold after exercise
404
$306.18
$123.70K
Andrew Reardon
2 Oct 2026
CLO & Secretary
Sold after exercise
1,535
$304.52
$467.43K
Andrew Reardon
2 Oct 2026
CLO & Secretary
Sold after exercise
1,976
$303.54
$599.80K
Andrew Reardon
2 Oct 2026
CLO & Secretary
Sold after exercise
833
$302.51
$251.99K
Jason Haas
12 Aug 2026
Director
Sold after exercise
7,138
$292.81
$2.09M
Octavio Espinoza
12 Aug 2026
Chief Financial Officer
Sold after exercise
31,641
$292.07
$9.24M
Andrew Reardon
3 Aug 2026
CLO & Secretary
Sold after exercise
409
$292.82
$119.76K
Andrew Reardon
3 Aug 2026
CLO & Secretary
Sold after exercise
991
$291.71
$289.09K
Andrew Reardon
3 Aug 2026
CLO & Secretary
Sold after exercise
200
$290.60
$58.12K
Andrew Reardon
3 Aug 2026
CLO & Secretary
Sold after exercise
503
$289.80
$145.77K
Andrew Reardon
3 Aug 2026
CLO & Secretary
Sold after exercise
356
$288.75
$102.79K
Andrew Reardon
3 Aug 2026
CLO & Secretary
Sold after exercise
1,214
$287.77
$349.36K
Andrew Reardon
3 Aug 2026
CLO & Secretary
Sold after exercise
1,032
$286.80
$295.97K
Andrew Reardon
3 Aug 2026
CLO & Secretary
Sold after exercise
157
$285.74
$44.86K
Andrew Reardon
3 Aug 2026
CLO & Secretary
Sold after exercise
33
$284.55
$9.39K
Andrew Reardon
3 Aug 2026
CLO & Secretary
Sold after exercise
105
$284.14
$29.83K
Andrew Reardon
1 Jul 2026
CLO & Secretary
Sold after exercise
600
$317.15
$190.29K
Andrew Reardon
1 Jul 2026
CLO & Secretary
Sold after exercise
900
$315.78
$284.20K
Andrew Reardon
1 Jul 2026
CLO & Secretary
Sold after exercise
100
$314.58
$31.46K
Andrew Reardon
1 Jul 2026
CLO & Secretary
Sold after exercise
700
$313.46
$219.42K
Andrew Reardon
1 Jul 2026
CLO & Secretary
Sold after exercise
1,081
$312.28
$337.57K
Andrew Reardon
1 Jul 2026
CLO & Secretary
Sold after exercise
1,119
$311.72
$348.81K
Andrew Reardon
1 Jul 2026
CLO & Secretary
Sold after exercise
104
$310.20
$32.26K
Andrew Reardon
1 Jul 2026
CLO & Secretary
Sold after exercise
396
$308.99
$122.36K
Stephen L Sabba
16 Jun 2026
Director
Sold after exercise
2,145
$254.00
$544.83K
Jason Haas
12 Jun 2026
Director
Sold after exercise
3,461
$256.08
$886.29K
Jason Haas
12 Jun 2026
Director
Sold after exercise
3,000
$255.01
$765.03K
Andrew Reardon
1 Jun 2026
CLO & Secretary
Sold after exercise
200
$230.41
$46.08K
Andrew Reardon
1 Jun 2026
CLO & Secretary
Sold after exercise
1,216
$229.47
$279.03K
Andrew Reardon
1 Jun 2026
CLO & Secretary
Sold after exercise
584
$228.57
$133.49K
Andrew Reardon
1 Jun 2026
CLO & Secretary
Sold after exercise
400
$226.78
$90.71K
Andrew Reardon
1 Jun 2026
CLO & Secretary
Sold after exercise
1,432
$225.97
$323.59K
Andrew Reardon
1 Jun 2026
CLO & Secretary
Sold after exercise
677
$225.20
$152.46K
Andrew Reardon
1 Jun 2026
CLO & Secretary
Sold after exercise
491
$223.95
$109.96K
John W Kozarich
13 May 2026
Director
Sold after exercise
1,575
$223.50
$352.01K
John W Kozarich
12 May 2026
Director
Sold after exercise
459
$224.00
$102.82K
Andrew Reardon
1 May 2026
CLO & Secretary
Sold after exercise
800
$234.02
$187.21K
Andrew Reardon
1 May 2026
CLO & Secretary
Sold after exercise
1,420
$232.92
$330.75K
Andrew Reardon
1 May 2026
CLO & Secretary
Sold after exercise
780
$232.04
$180.99K
Andrew Reardon
1 May 2026
CLO & Secretary
Sold after exercise
370
$230.87
$85.42K
Andrew Reardon
1 May 2026
CLO & Secretary
Sold after exercise
98
$229.71
$22.51K
Andrew Reardon
1 May 2026
CLO & Secretary
Sold after exercise
932
$228.75
$213.20K
Andrew Reardon
1 May 2026
CLO & Secretary
Sold after exercise
600
$227.45
$136.47K
Andrew Reardon
1 Apr 2026
CLO & Secretary
Sold after exercise
337
$204.50
$68.92K
Andrew Reardon
1 Apr 2026
CLO & Secretary
Sold after exercise
963
$203.22
$195.70K
Andrew Reardon
1 Apr 2026
CLO & Secretary
Sold after exercise
700
$201.90
$141.33K
Andrew Reardon
1 Apr 2026
CLO & Secretary
Sold after exercise
1,238
$200.94
$248.77K
Andrew Reardon
1 Apr 2026
CLO & Secretary
Sold after exercise
1,302
$199.72
$260.04K
Andrew Reardon
1 Apr 2026
CLO & Secretary
Sold after exercise
460
$198.85
$91.47K
Octavio Espinoza
11 Mar 2026
Chief Financial Officer
Sold after exercise
3,057
$225.00
$687.83K
John L Lamattina
6 Mar 2026
Director
Sold after exercise
2,161
$200.76
$433.84K
Octavio Espinoza
4 Mar 2026
Chief Financial Officer
Sold after exercise
3,413
$208.80
$712.62K
Octavio Espinoza
4 Mar 2026
Chief Financial Officer
Sold after exercise
2,457
$207.91
$510.82K
Octavio Espinoza
4 Mar 2026
Chief Financial Officer
Sold after exercise
1,588
$206.89
$328.54K
Octavio Espinoza
4 Mar 2026
Chief Financial Officer
Sold after exercise
1,457
$205.79
$299.84K
Octavio Espinoza
4 Mar 2026
Chief Financial Officer
Sold after exercise
743
$204.74
$152.13K
Octavio Espinoza
4 Mar 2026
Chief Financial Officer
Sold after exercise
668
$203.63
$136.02K
Octavio Espinoza
4 Mar 2026
Chief Financial Officer
Sold after exercise
697
$202.79
$141.34K
Octavio Espinoza
4 Mar 2026
Chief Financial Officer
Sold after exercise
950
$201.73
$191.64K
Octavio Espinoza
4 Mar 2026
Chief Financial Officer
Sold after exercise
698
$201.09
$140.36K
Octavio Espinoza
4 Mar 2026
Chief Financial Officer
Sold after exercise
53
$200.08
$10.60K
Octavio Espinoza
4 Mar 2026
Chief Financial Officer
Sold after exercise
699
$198.71
$138.89K
Andrew Reardon
4 Mar 2026
CLO & Secretary
Sold after exercise
1,142
$208.87
$238.53K
Andrew Reardon
4 Mar 2026
CLO & Secretary
Sold after exercise
1,446
$208.12
$300.94K
Andrew Reardon
4 Mar 2026
CLO & Secretary
Sold after exercise
612
$207.01
$126.69K
Andrew Reardon
4 Mar 2026
CLO & Secretary
Sold after exercise
340
$206.37
$70.16K
Andrew Reardon
4 Mar 2026
CLO & Secretary
Sold after exercise
460
$205.18
$94.38K
Andrew Reardon
4 Mar 2026
CLO & Secretary
Sold after exercise
200
$204.17
$40.83K
Andrew Reardon
4 Mar 2026
CLO & Secretary
Sold after exercise
300
$201.70
$60.51K
Andrew Reardon
4 Mar 2026
CLO & Secretary
Sold after exercise
93
$200.62
$18.66K
Andrew Reardon
4 Mar 2026
CLO & Secretary
Sold after exercise
207
$199.96
$41.39K
Andrew Reardon
4 Mar 2026
CLO & Secretary
Sold after exercise
100
$199.01
$19.90K
Andrew Reardon
4 Mar 2026
CLO & Secretary
Sold after exercise
100
$197.70
$19.77K
Stephen L Sabba
3 Mar 2026
Director
Sold after exercise
2,034
$201.50
$409.85K
John L Lamattina
7 Nov 2025
Director
Sold after exercise
2,034
$205.45
$417.89K
John L Lamattina
7 Nov 2025
Director
Sold after exercise
2,145
$205.45
$440.69K
Nancy Ryan Gray
7 Nov 2025
Director
Sold after exercise
3,015
$205.45
$619.43K
Nancy Ryan Gray
7 Nov 2025
Director
Sold after exercise
3,556
$205.45
$730.58K
Show all 154 transactions →

What was left out

Form 4 filings counted 52
Amendments (4/A) skipped 0
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 38
Sales straight out of an exercise 93
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 281,927
History held since 29 Sep 2006